https://www.premera.com/medicalpolicies/5.01.599.pdf#search=policy
PHARMACY POLICY - 5.01.599 Pharmacologic Treatment of Sleep Disorders Effective Date: ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.610.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.610 Pharmacologic Treatment in Assisted Reproduction ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.614.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.614 Erythroid Maturation Agents Effective Date: Nov. 1, ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.621.pdf#search=policy
PHARMACY POLICY - 5.01.621 Drugs for Weight Management Effective Date: Dec. 1, 2023 Last ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.630.pdf#search=policy
MEDICAL POLICY - 5.01.630 Intravenous Iron Replacement Products Effective Date: April 1, ... POLICY CRITERIA | CODING | RELATED INFORMATION | EVIDENCE REVIEW | REFERENCES | APPENDIX | ...
https://www.premera.com/medicalpolicies/7.01.101.pdf#search=policy
MEDICAL POLICY - 7.01.101 Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome BCBSA Ref. Policy: 7.01.101 Effective Date: Jan. 1, 2024 Last Revised: Dec. 26, 2023 ...
https://www.premera.com/medicalpolicies/7.01.165.pdf#search=policy
MEDICAL POLICY - 7.01.165 Radiofrequency Coblation Tenotomy for Musculoskeletal Conditions BCBSA Ref. Policy: 7.01.165 Effective Date: Mar. 1, 2024 Last Revised: Feb. 12, 2024 ...
https://www.premera.com/medicalpolicies/8.01.17.pdf#search=policy
MEDICAL POLICY - 8.01.17 Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome BCBSA Ref. Policy: 8.01.17 Effective Date: ...
https://www.premera.com/medicalpolicies/8.01.63.pdf#search=policy
MEDICAL POLICY - 8.01.63 Chimeric Antigen Receptor Therapy for Leukemia and Lymphoma BCBSA Ref. Policy: 8.01.63 Effective Date: April 1, 2024 Last Revised: Mar. 25, 2024 Replaces: ...
https://www.premera.com/medicalpolicies/1.01.24.pdf#search=policy
MEDICAL POLICY - 1.01.24 Interferential Current Stimulation BCBSA Ref. Policy: 1.01.24 Effective Date: Sept. 1, 2023 Last Revised: Oct. 4, 2023 Replaces: N/A RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/1.01.538.pdf#search=policy
MEDICAL POLICY - 1.01.538 Cooling Devices Used in the Outpatient Setting BCBSA Ref. Policy: 1.01.26 Effective Date: June 1, 2023 Last Revised: May 9, 2023 Replaces: 1.01.26 ...
https://www.premera.com/medicalpolicies/1.01.539.pdf#search=policy
MEDICAL POLICY - 1.01.539 Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions BCBSA Ref. Policy: 1.01.15 Effective Date: Sept. 1, 2023 Last ...
https://www.premera.com/medicalpolicies/2.01.100.pdf#search=policy
MEDICAL POLICY - 2.01.100 Dry Needling of Trigger Points for Myofascial Pain BCBSA Ref. Policy: 2.01.100 Effective Date: Dec. 7, 2023 Last Revised: Aug. 8, 2023 Replaces: N/A ...
https://www.premera.com/medicalpolicies/2.04.136.pdf#search=policy
MEDICAL POLICY - 2.04.136 Nutrient/Nutritional Panel Testing BCBSA Ref. Policy: 2.04.136 Effective Date: Mar. 1, 2024 Last Revised: Feb. 12, 2024 Replaces: N/A RELATED MEDICAL ...
https://www.premera.com/medicalpolicies/2.04.516.pdf#search=policy
MEDICAL POLICY - 2.04.516 Measurement of Serum Antibodies to Selected Biologic Agents BCBSA Ref. Policy: 2.04.84 Effective Date: Feb. 1, 2024 Last Revised: Jan. 9, 2024 Replaces: ...
https://www.premera.com/medicalpolicies/5.01.532.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.532 Cutaneous T-Cell Lymphomas (CTCL): Systemic ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.551.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.551 Use of Granulocyte Colony-Stimulating Factors ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.563_2024-06-07.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.563 Pharmacotherapy of Inflammatory Bowel Disorder ... Revised: April 1, 2024 Replaces: Extracted from 5.01.550 *View the current policy here. ...
https://www.premera.com/medicalpolicies/5.01.568.pdf#search=policy
PHARMACY POLICY - 5.01.568 Venclexta (venetoclax) BCL-2 Inhibitor Effective Date: Oct. 1, ... POLICY CRITERIA | CODING | RELATED INFORMATION EVIDENCE REVIEW | REFERENCES | HISTORY ∞ ...
https://www.premera.com/medicalpolicies/5.01.609.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.609 Spravato (esketamine) Nasal Spray Effective Date: ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...